Livongo, a consumer health company empowering people with chronic conditions to live better and healthier lives, today announced the first voice-enabled, at-home, cellular blood pressure monitoring system, free medication incentives for eligible members, and a number of new data science capabilities and partnerships. This voice-enabled cellular BP monitoring system builds on Livongo’s previously announced cellular blood pressure monitoring system, which allows members to instantly and effortlessly upload readings to the Livongo cloud (Cuff to CloudTM). This next generation system will allow a user to easily interact with Livongo via voice at each check. The innovation enables a whole new way to deliver actionable, personalized and timely health signals that can lead to behavior change and clinical outcomes.
These innovations support the company’s introduction of Applied Health Signals, a new category of technologies and capabilities that for the first time combines data science, behavior enablement, and clinical impact to help make it easier for people with chronic conditions to stay healthy.
What is Applied Health Signals?
Health signals are created by an individual’s behaviors, health status, lifestyle, and preferences. These signals can guide individuals and their care providers to proactively make changes to optimize clinical outcomes. Too often, people living with chronic conditions are presented with too many health data points to take meaningful action. Livongo quiets the noise by four pillars: aggregating, interpreting, applying, and iterating (AI+AI) health signals to make healthy behaviors more accessible.
Livongo has built the technology and capability for all four pillars to deliver actionable, personalized, and timely insights, information, and nudges that are relevant and impactful for people with chronic conditions. Unlike many digital health companies that focus on a single condition, address one aspect of a problem, or deliver a narrow set of consumer applications, Livongo is unique because it excels at all four pillars of Applied Health Signals and applies a broad set of health signals across multiple conditions.
Livongo announced today that eligible Livongo members can receive co-pay waivers on medications making their medications free. This innovation overcomes the critical access barrier of cost and leverages personalized data insights to motivate healthy behaviors that can lead to clinical outcomes.
Partnership with Medisafe
In addition, Livongo is also bringing key partners to research data sets and uncover new outcome-focused health signals that will improve the Livongo Applied Health Signals Engine over time. Today, Livongo announced a partnership with Medisafe that will improve medication management for people with chronic conditions and further its data and capabilities in the Applied Health Signals category.
“It’s exciting to introduce products that change the way people think about and experience chronic conditions. We did that in diabetes, with unlimited free strips, cellular-connected meters, insights and care accessible 24 hours a day anywhere, all of which made it easier for our members to stay healthy. Now we’re doing the same thing for hypertension,” said Amar Kendale, Livongo’s Chief Product Officer. “By delivering blood pressure feedback in a new relevant way and by driving positive behavior change with medication incentives, we are reducing the confusion, complexity, and cost of healthcare for our members. We are making healthcare less noisy and paving the way for meaningful and measurable change. That’s what Applied Health Signals is all about.”